Universal Biosensors, Inc. (ASX:UBI) Partners with Chewy and Amazon
Partnerships with Leading Retailers
Universal Biosensors, Inc. (ASX: UBI) has signed a Vendor Master Purchase Agreement with Chewy, Inc., a major pet retailer in the USA. Chewy generated over USD $11 billion in revenue in 2023 and boasts more than 20 million active customers. In addition, UBI has launched the Petrackr product on Amazon, enhancing its ecommerce strategy.
Sales Strategy and Market Impact
The agreements with Chewy and Amazon, which can be terminated by either party with 30 days’ notice, follow an extensive nine-month collaboration to build UBI’s ecommerce capability. Mr. John Sharman, Managing Director of Universal Biosensors, stated, “Our initial focus for the launch of Petrackr was to the professional vet network…the majority of sales for vet blood glucose monitoring systems are online.” Sharman emphasised the importance of these partnerships, mentioning that Chewy and Amazon are the largest retailers of veterinary products in North America, expecting a material impact on Petrackr sales moving forward.
Motley Fool contributor Lianne Eastty has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.